Litao pharmaceutical technology co., ltd. recently completed the construction of an ion channel drug research and development platform, which currently has an electrophysiological manual patch clamp system and a calcium ion imaging system. The platform can detect and evaluate all ligand-gated and voltage-gated ion channels, conduct drug screening for ion channel targets, and conduct early safety pharmacological studies (including comprehensive drug cardiac safety studies).

Glass way pharmaceutical technology co., LTD, Shanghai has a rich experience in the field of ion channel drug research and development team, the company's research and development pipeline to focus on the pain associated with ion channel, epilepsy, depression and nervous system diseases such as neurodegenerative diseases, ion channel drug research and development platform was built after the operation will further enhance the company's research and development efficiency and core competitiveness.